You are here: Industry Insights > antipsychotic

News List

Antipsychotic Use Safer Than No Use in Schizophrenia drugs
January 20, 2020
Among patients with schizophrenia, long-term antipsychotic use does not appear to increase severe physical morbidity or somatic hospitalization, and mortality is lower for antipsychotic use compared with no use ...
Intra-Cellular nabs nod for schizophrenia drug after FDA twists fiercepharma
December 31, 2019
Intra-Cellular Therapies had quite a journey toward an FDA decision on its antipsychotic contender. It involved mixed clinical data, a canceled advisory committee meeting and a three-month review extension.
Antipsychotic Rx Patterns in Children With ADHD Concerning drugs
August 16, 2019
While the number of young people with attention-deficit/hyperactivity disorder (ADHD) who are treated with antipsychotic drugs is low...
Study examines antipsychotic medication for children with autism europeanpharmaceuticalreview
April 25, 2019
Children with intellectual difficulty or autism are more likely to be given antipsychotic medication from a younger age than those without intellectual disability…
Alzheimer’s disease patients often show psychotropic polypharmacy europeanpharmaceuticalreview
April 17, 2019
The results of the study were said to be concerning because previous research had linked psychotropic drug use among older people and patients with dementia to several adverse events…